Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 2 | Cost Effectiveness and Resource Allocation

Fig. 2

From: Optimizing strategy for cervical cancer prevention in china: a comprehensive modeling analysis

Fig. 2

Effectiveness analysis of cervical cancer prevention strategies. The number"(64)"indicates that the screening coverage age is 35–64 years. If"(64)"is not present, it refers to the age group of 35–45 years. For example, VIA (64) + 2v represents VIA screening for women aged 35–64 years combined with the bivalent HPV vaccine (2v) for girls aged 9–14 years. In addition, to better illustrate the results, we have only listed the no-intervention and the strategies mentioned earlier in the text. The timeframes for other strategies that can achieve the target effectiveness are provided in Appendix Table 3

Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us